Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New data confirm oral bioavailability of AL-309

April 26, 2007

NS-2359 begins second phase II study for depression

April 26, 2007

Two phase I studies of PTC-124 in healthy adults completed

April 26, 2007

Synosia in-licenses rufinamide for anxiety disorders and bipolar mood disorders

April 25, 2007

Phase IIa biomarker study investigates HF-0220 in mild to moderate Alzheimer's

April 25, 2007

New diagnostic agents for schizophrenia reported by Merck

April 24, 2007

ADX-10059 meets primary endpoint in migraine study

April 24, 2007

Keppra effective as adjunctive therapy in partial onset seizures in young children

April 23, 2007

E-2007 studied to lengthen effectiveness of L-dopa treatment in Parkinson's

April 23, 2007

Novel Alzheimer's vaccine candidate developed at UBI

April 23, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...